Abstract
MACROPHAGES can have critical roles in repair, inflammation and a large variety of immunological phenomena1,2. The biological roles of these cells often occur subsequent to their ‘activation’, a subjective term which refers to a greatly heightened state of reactivity1–3. Activation can be induced by a variety of stimuli including ingestion of certain macro-organisms, contact with immune complexes, bacterial lipopolysaccharides and lymphokines3. Activated macrophages usually show an increase in cell size, increased adherence properties and cellular processes, lysosomal enzyme activity, and phagocytic ability1,2. In addition, alteration in characteristics and functions of various macrophage receptors can apparently take place as a consequence of activation4,5. Such a change is described in this paper: it involves Fc receptors as detected by Fc or EA rosette formation (see Table 1), and their relationship to surface mouse major histocompatibility (H–2) antigens as detected by anti-H–2 alloantisera. Aside from the general relevance this change has with regard to membrane alterations which occur in activated lymphoreticular cells, it can also be exploited as a marker for activated macrophages.
Similar content being viewed by others
References
Nelson, D., in The Macrophage in Immunology (North Holland, Amsterdam, 1969).
Mackaness, G., in The Mononuclear Phagocyte (edit. by Van Furth, R.) (Blackwell London, 1970).
Sheagren, J. N., and Hahn, H., Progr. Immun., 2, 325 (1974).
Rhodes, J., J. Immun., 114, 976 (1975).
Bianco, C., Griffin, F. M., and Silverstein, S. C., J. exp. Med., 141, 1278 (1975).
Schirrmacher, V., Halloran, P., and David, C. S., J. exp. Med., 141, 1201 (1975).
Parish, C. R., and Hayward, J. A., Proc. R. Soc., B 187, 47 (1974).
Gery, I., Krüger, J., and Spiesel, S. Z., J. Immun., 4, 1008 (1972).
Yoshida, T.O., and Andersson, B., Scand. J. Immun., 1, 401 (1972).
Koren, H. S., Handwerger, B. S., and Wunderlich, J. R., J. Immun., 114, 894 (1975).
Evans, R., Transplantation, 14, 468 (1972).
Kerbel, R. S., Pross, H. F., and Elliott, E. V., Int. J. Cancer, 15, 918 (1974).
Van Loveren, H., and Den Otter, W., J. natn. Cancer Inst., 54, 387 (1975).
Arend, W. P., and Mannick, M., J. Immun., 110, 1455 (1973).
McDevitt, H. O., Becktol, K. B., Hammerling, G. J., Lonai, P., and Debovitch, T. L., in The Immune System: Genes, Receptors and Signals (edit. by Sercarz, Williamson and Fox) (Academic, New York, 1974).
Martinez, J. P., Schirrmacher, V., Garrido, F., and Festenstein, H., J. Immunogenet., (in the press).
Halloran, P., Schirrmacher, V., David, C. S., and Staines, N. A., Immunogenetics (in the press).
Koene, R. A. P., and McKenzie, I. F. C., J. Immun., 111, 1894 (1973).
Sprent, J., and Miller, J. F. A. P., Cell. Immun., 3, 385 (1972).
Kerbel, R. S., and Doenhoff, M. J., Nature, 250, 342 (1974).
Hauptfield, M., Hauptfield, V., and Klein, J., Transplantation, 12, 231 (1975).
Griffin, F. M., and Silverstein, S. C., J. exp. Med., 139, 323 (1974).
Jondal, M., Scand. J. Immun., 3, 739 (1975).
Kerbel, R. S., Birbeck, M. S. C., Robertson, D., and Cartwright, P., Clin. exp. Immun., 20, 161 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
KERBEL, R. Resistance of activated macrophages to H–2 antibody-mediated cytotoxicity and Fc rosette inhibition. Nature 259, 226–228 (1976). https://doi.org/10.1038/259226a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/259226a0
- Springer Nature Limited